From: miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer
Cell line | MDA-MB-231 | MCF7 |
---|---|---|
Cancer subtype | Basal-like | Luminal |
ER status | ER negative | ER positive |
Proliferation change with S100A7 overexpression | ↑ 57%* | ↓ 33%* |
Morphology change with S100A7 overexpression | Gained mesenchymal | Gained epithelial |
Tumor growth with S100A7 overexpression | ↑ 1089%* | ↓ 79%* |